• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Bullous Pemphigoid and Dipeptidyl Peptidase 4 Inhibitors: A Disproportionality Analysis Based on the Japanese Adverse Drug Event Report Database.

作者信息

Arai Masanori, Shirakawa Jun, Konishi Hiromi, Sagawa Naoko, Terauchi Yasuo

机构信息

Department of Endocrinology and Metabolism, Graduate School of Medicine, Yokohama City University, Yokohama, Japan.

Department of Endocrinology and Metabolism, Graduate School of Medicine, Yokohama City University, Yokohama, Japan

出版信息

Diabetes Care. 2018 Sep;41(9):e130-e132. doi: 10.2337/dc18-0210. Epub 2018 Jul 12.

DOI:10.2337/dc18-0210
PMID:30002201
Abstract
摘要

相似文献

1
Bullous Pemphigoid and Dipeptidyl Peptidase 4 Inhibitors: A Disproportionality Analysis Based on the Japanese Adverse Drug Event Report Database.大疱性类天疱疮与二肽基肽酶4抑制剂：基于日本药品不良事件报告数据库的不成比例性分析
Diabetes Care. 2018 Sep;41(9):e130-e132. doi: 10.2337/dc18-0210. Epub 2018 Jul 12.
2
Bullous pemphigoid and dipeptidyl peptidase IV inhibitors: a case-noncase study in the French Pharmacovigilance Database.大疱性类天疱疮与二肽基肽酶-4 抑制剂：法国药物警戒数据库中的病例对照研究。
Br J Dermatol. 2016 Aug;175(2):296-301. doi: 10.1111/bjd.14601. Epub 2016 Jul 19.
3
Dipeptidyl peptidase-IV inhibitors induced bullous pemphigoid: a case report and analysis of cases reported in the European pharmacovigilance database.二肽基肽酶-IV抑制剂诱发大疱性类天疱疮：一例报告及欧洲药物警戒数据库中报告病例的分析
J Clin Pharm Ther. 2016 Jun;41(3):368-370. doi: 10.1111/jcpt.12397.
4
Drug-induced bullous pemphigoid in diabetes mellitus patients receiving dipeptidyl peptidase-IV inhibitors plus metformin.二肽基肽酶-4 抑制剂联合二甲双胍治疗糖尿病患者引起的药物性大疱性类天疱疮。
J Eur Acad Dermatol Venereol. 2012 Feb;26(2):249-53. doi: 10.1111/j.1468-3083.2011.04062.x. Epub 2011 Apr 6.
5
Bullous pemphigoid induced by vildagliptin: a report of three cases.维格列汀诱发的大疱性类天疱疮：三例报告
Fundam Clin Pharmacol. 2015 Feb;29(1):112-4. doi: 10.1111/fcp.12083. Epub 2014 Jun 9.
6
Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System.二肽基肽酶-4抑制剂与心力衰竭：提交至美国食品药品监督管理局不良事件报告系统的自发报告分析
Nutr Metab Cardiovasc Dis. 2016 May;26(5):380-6. doi: 10.1016/j.numecd.2016.02.006. Epub 2016 Feb 19.
7
A case report of bullous pemphigoid induced by dipeptidyl peptidase-4 inhibitors.二肽基肽酶-4抑制剂诱发大疱性类天疱疮一例报告
JAMA Dermatol. 2013 Feb;149(2):243-5. doi: 10.1001/jamadermatol.2013.1073.
8
Three Cases of Bullous Pemphigoid Associated with Dipeptidyl Peptidase-4 Inhibitors - One due to Linagliptin.三例与二肽基肽酶-4抑制剂相关的大疱性类天疱疮——其中一例由利格列汀引起。
Dermatology. 2016;232(2):249-53. doi: 10.1159/000443330. Epub 2016 Jan 28.
9
Signal of Miscarriage with Aripiprazole: A Disproportionality Analysis of the Japanese Adverse Drug Event Report Database.阿立哌唑致流产信号：日本不良药物事件报告数据库的比例失调分析。
Drug Saf. 2017 Nov;40(11):1141-1146. doi: 10.1007/s40264-017-0560-z.
10
Bullous Pemphigoid Associated With Linagliptin Treatment.与利格列汀治疗相关的大疱性类天疱疮
JAMA Dermatol. 2016 Feb;152(2):224-6. doi: 10.1001/jamadermatol.2015.2939.

引用本文的文献

1
Bullous pemphigoid associated with vildagliptin in an elderly adult with diabetes mellitus. First case in Peru.在一名患有糖尿病的老年成人中，维格列汀与大疱性类天疱疮相关。秘鲁首例病例。
Rev Peru Med Exp Salud Publica. 2025 Jun 9;42(1):97-101. doi: 10.17843/rpmesp.2025.421.13871.
2
A pharmacovigilance study on clinical factors of active vitamin D analog-related acute kidney injury using the Japanese Adverse Drug Event Report Database.一项使用日本药品不良反应报告数据库的活性维生素 D 类似物相关急性肾损伤临床因素的药物警戒研究。
Sci Rep. 2024 Sep 12;14(1):21356. doi: 10.1038/s41598-024-72505-w.
3
A consensus statement from the Japan Diabetes Society (JDS): a proposed algorithm for pharmacotherapy in people with type 2 diabetes-2nd Edition (English version).
日本糖尿病学会（JDS）共识声明：2型糖尿病患者药物治疗的推荐算法 - 第2版（英文版）
Diabetol Int. 2024 Jul 11;15(3):327-345. doi: 10.1007/s13340-024-00723-8. eCollection 2024 Jul.
4
A consensus statement from the Japan Diabetes Society: A proposed algorithm for pharmacotherapy in people with type 2 diabetes - 2nd edition (English version).日本糖尿病学会共识声明：2 型糖尿病药物治疗建议算法-第 2 版（英文版）。
J Diabetes Investig. 2024 Sep;15(9):1326-1342. doi: 10.1111/jdi.14202. Epub 2024 Jul 11.
5
Two cases of linagliptin-associated bullous pemphigoid resulting in sepsis and endocarditis.两例利拉利汀相关大疱性类天疱疮导致败血症和心内膜炎。
BMJ Case Rep. 2024 Feb 13;17(2):e255358. doi: 10.1136/bcr-2023-255358.
6
A case of bullous pemphigoid and renal disease after dipeptidyl peptidase 4 inhibitor administration.一例使用二肽基肽酶4抑制剂后发生大疱性类天疱疮和肾脏疾病的病例。
CEN Case Rep. 2024 Aug;13(4):264-270. doi: 10.1007/s13730-023-00835-1. Epub 2023 Dec 6.
7
Liver injury in children: signal analysis of suspected drugs based on the food and drug administration adverse event reporting system.儿童肝损伤：基于食品药品监督管理局不良事件报告系统的可疑药物信号分析。
BMC Pediatr. 2023 Sep 28;23(1):492. doi: 10.1186/s12887-023-04097-9.
8
The effect of dipeptidyl peptidase-4 inhibitor on incidence and clinical course in bullous pemphigoid patients in a tertiary medical center.三级医疗中心中双肽基肽酶-4抑制剂对大疱性类天疱疮患者发病率及临床病程的影响
Kaohsiung J Med Sci. 2023 Oct;39(10):1038-1044. doi: 10.1002/kjm2.12731. Epub 2023 Aug 2.
9
Effect of early initiation of steroid-sparing drugs in patients with bullous pemphigoid.大疱性类天疱疮患者中早期起始应用皮质类固醇激素节省药物的效果。
Front Immunol. 2023 Jul 6;14:1176284. doi: 10.3389/fimmu.2023.1176284. eCollection 2023.
10
Ideal automation for insulin management - with interpretation of risk ratio.胰岛素管理的理想自动化——风险比解读。
Lancet Reg Health West Pac. 2023 Apr 8;35:100761. doi: 10.1016/j.lanwpc.2023.100761. eCollection 2023 Jun.